In this study, we have shown that the addition of anti-CTLA-4 antibody to tumor fragments from metastatic ovarian cancer does not only promote the outgrowth of TILs but also favors the propagation of CD8+ T cells and thus enhances the anti-tumor reactivity of TILs. This evidence concerns the gene CD8A and neoplasm.